Advanced search
Publication Cover
Drug Development and Industrial Pharmacy Volume 44, 2018 - Issue 4
Submit an article Journal homepage
222
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Development of optimized self-nanoemulsifying lyophilized tablets (SNELTs) to improve finasteride clinical pharmacokinetic behavior

Tarek A. AhmedDepartment of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia; ;Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt; Correspondence[email protected] [email protected]
View further author information
,
Khalid M. El-SayDepartment of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia; ;Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt; View further author information
,
Khaled M. HosnyDepartment of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia; ;Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, EgyptView further author information
&
Bader M. AljaeidDepartment of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia; View further author information
Pages 652-661 | Received 21 Aug 2017, Accepted 12 Nov 2017, Published online: 29 Nov 2017

References

  • Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci. 2006;29:278–287.
  • Ahmed OAA, Badr-Eldin SM, Tawfik MK, et al. Design and optimization of self-nanoemulsifying delivery system to enhance quercetin hepatoprotective activity in paracetamol-induced hepatotoxicity. J Pharm Sci. 2014;103:602–612.
  • Al-Subaie MM, Hosny KM, El-Say KM, et al. Utilization of nanotechnology to enhance percutaneous absorption of acyclovir in the treatment of herpes simplex viral infections. Int J Nanomed. 2015;10:3973–3985.
  • El-Say KM, Ahmed TA, Badr-Eldin SM, et al. Enhanced permeation parameters of optimized nanostructured simvastatin transdermal films: ex vivo and in vivo evaluation. Pharm Dev Technol. 2015;20:919–926.
  • Faller B, Farley D, Nick H. Finasteride: a slow-binding 5 alpha-reductase inhibitor. Biochemistry. 1993;32:5705–5710.
  • Wilde M, Goa K. Finasteride: an update of its use in the management of symptomatic benign prostatic hyperplasia. Drugs. 1999;57:557–581.
  • Gravas S, Oelke M. Current status of 5alpha-reductase inhibitors in the management of lower urinary tract symptoms and BPH. World J Urol. 2010;28:9–15.
  • Kumar VL, Wahane VD. Current status of 5alpha-reductase inhibitors in the treatment of benign hyperplasia of prostate. Indian J Med Sci. 2008;62:167–175.
  • Steiner JF. Clinical pharmacokinetics and pharmacodynamics of finasteride. Clin Pharmacokinet. 1996;30:16–27.
  • El-Say KM, Ahmed TA, Ahmed OAA, et al. Self-Nanoemulsifying lyophilized tablets for flash oral transmucosal delivery of vitamin K: development and clinical evaluation. J Pharm Sci. 2017;106:2447–2456.
  • Sznitowska M, Płaczek M, Klunder M. The physical characteristics of lyophilized tablets containing a model drug in different chemical forms and concentrations. Acta Poloniae Pharm. 2005;62:25–29.
  • The United States Pharmacopeia, T.N.F. 2005. Usp 28/Nf 23, Rockville, MD, USA: US Pharmacopoeial Convention Inc.
  • Ahmed TA, El-Say KM. Transdermal film-loaded finasteride microplates to enhance drug skin permeation: two-step optimization study. Eur J Pharm Sci. 2016;88:246–256.
  • Parmar N, Singla N, Amin S, et al. Study of cosurfactant effect on nanoemulsifying area and development of lercanidipine loaded (SNEDDS) self nanoemulsifying drug delivery system. Colloids Surf B Biointerfaces. 2011;86:327–338.
  • Azeem A, Rizwan M, Ahmad FJ, et al. Nanoemulsion components screening and selection: a technical note. AAPS PharmSciTech. 2009;10:69–76.
  • Hazelwood LA, Daran J-M, van Maris AJA, et al. The Ehrlich pathway for fusel alcohol production: a century of research on Saccharomyces cerevisiae metabolism. Appl Environ Microbiol. 2008;74:2259–2266.
  • Hernandez O. 2005. n-Butanol, SIDS Initial Assessment Report. Geneva [Internet]. Available from: http://www.inchem.org/documents/sids/sids/71363.pdf.
  • Ahmed T, Mahmoud MF, Samy AM, et al. Formulation, evaluation and optimization of miconazole nitrate tablet prepared by foam granulation technique. Int J Drug Deliv. 2011;3:712–733.
  • Chandrasekhar R, Hassan Z, AlHusban F, et al. The role of formulation excipients in the development of lyophilised fast-disintegrating tablets. Eur J Pharm Biopharm. 2009;72:119–129.
  • Djagny KB, Wang Z, Xu S. Gelatin: a valuable protein for food and pharmaceutical industries: review. Crit Rev Food Sci Nutr. 2001;41:481–492.
  • U.S. Food and Drug Administration, [Internet]. Guidance for industry impurities: residual solvents VICH GL18 draft guidance; 1999. Available from: https://www.fda.gov/ohrms/dockets/98fr/994071gd.pdf.
  • Thoorens G, Krier F, Leclercq B, et al. Microcrystalline cellulose, a direct compression binder in a quality by design environment—a review. Int J Pharm. 2014;473:64–72.
  • Bolhuis GK, Anthony Armstrong N. Excipients for direct compaction—an update. Pharm Dev Technol. 2006;11:111–124.
  • Wang J, Wen H, Desai D. Lubrication in tablet formulations. Eur J Pharm Biopharm. 2010;75:1–15.
  • Reier GE. 2000. Avicel PH microcrystalline cellulose, NF, Ph Eur., JP, BP. FMC Corporation, pp.1–27.
  • Jain SP, Mehta DC, Shah SP, et al. Melt-in-mouth pellets of fexofenadine hydrochloride using crospovidone as an extrusion–spheronisation aid. AAPS PharmSciTech. 2010;11:917–923.
  • Schiermeier S, Schmidt PC. Fast dispersible ibuprofen tablets. Eur J Pharm Sci. 2002;15:295–305.
  • Ahmed T. Preparation of finasteride capsules-loaded drug nanoparticles: formulation, optimization, in vitro, and pharmacokinetic evaluation. Int J Nanomed. 2016;11:515–527.
  • Nagalaxmi V, Mahipal R, Manikanta K, et al. Formulation and evaluation of controlled release matrix tablets of finasteride. Int J Pharm Dev Technol. 2014;4:63–70.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.